Pages that link to "Q37064670"
Jump to navigation
Jump to search
The following pages link to Hepatitis B virus escape mutants induced by antiviral therapy (Q37064670):
Displaying 50 items.
- Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation (Q26772036) (← links)
- Overview of hepatitis B virus mutations and their implications in the management of infection (Q26772346) (← links)
- The Role of Oxidative Stress and Antioxidants in Liver Diseases (Q26779146) (← links)
- Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses? (Q27487167) (← links)
- Genetic Characterization of Hepatitis B Virus in Peripheral Blood Leukocytes: Evidence for Selection and Compartmentalization of Viral Variants with the Immune Escape G145R Mutation (Q27489690) (← links)
- Key role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinoma (Q28084458) (← links)
- Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India (Q28536346) (← links)
- Pre-existing mutations in reverse transcriptase of hepatitis B virus in treatment-naive Chinese patients with chronic hepatitis B (Q28545179) (← links)
- Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules (Q28741431) (← links)
- Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? (Q33574740) (← links)
- Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. (Q34080966) (← links)
- Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China (Q34947605) (← links)
- Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients. (Q35706679) (← links)
- Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees (Q35762179) (← links)
- Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. (Q35964704) (← links)
- Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain (Q36743921) (← links)
- High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation (Q36747829) (← links)
- Management of hepatitis B virus co-infection on and off antiretroviral therapy (Q37176668) (← links)
- A function essential to viral entry underlies the hepatitis B virus "a" determinant (Q37333982) (← links)
- Genotyping and Mutation Pattern in the Overlapping MHR Region of HBV Isolates in Southern Khorasan, Eastern Iran (Q37417336) (← links)
- Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. (Q37478309) (← links)
- Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil (Q37502756) (← links)
- Molecular methods in the diagnosis and management of chronic hepatitis B (Q37801940) (← links)
- Selection of chronic hepatitis B therapy with high barrier to resistance (Q37983258) (← links)
- Management and treatment of chronic hepatitis B in HIV-positive patients (Q38203324) (← links)
- Potential mutations associated with occult hepatitis B virus status (Q38211852) (← links)
- Advances in treating drug-resistant hepatitis B virus in HIV-infected patients. (Q38296047) (← links)
- Lamivudine resistance in children with chronic hepatitis B. (Q38456918) (← links)
- Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis (Q39375780) (← links)
- Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B. (Q39707885) (← links)
- Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains (Q39778916) (← links)
- Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B. (Q40109822) (← links)
- Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia (Q41356321) (← links)
- Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases (Q41746406) (← links)
- Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. (Q44047772) (← links)
- Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B. (Q44150241) (← links)
- Molecular characterization of hepatitis B virus in Bangladesh reveals a highly recombinant population (Q45323648) (← links)
- Mutations in the S gene region of hepatitis B virus genotype D in Golestan Province-Iran. (Q45360174) (← links)
- Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites (Q45363333) (← links)
- Characterization of hepatitis virus B isolated from a multi-drug refractory patient (Q45372133) (← links)
- Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China (Q48053718) (← links)
- Why does drug resistance readily evolve but vaccine resistance does not? (Q51219718) (← links)
- Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. (Q55019535) (← links)
- Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma. (Q55119883) (← links)
- Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen (Q56918262) (← links)
- Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana (Q57159588) (← links)
- Editorial (Q57930358) (← links)
- Molecular Variants of Hepatitis B Surface Antigen (HBsAg) (Q58808840) (← links)
- Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis (Q61454966) (← links)
- Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications (Q64085670) (← links)